TrialThe Lancet. Global health2024

Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.

Kathy Baisley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.